Furusyo, Norihiro <br/><br/>
Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Jul 2008 
 - 1094-104 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2008.05319.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Asian People<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--diagnosis<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Japan<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load